All the news Showing 10 of 93 articles from: HCV and coinfectionsGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Training manual for treatment advocates: Hepatitis C virus and coinfection with HIV TAG / 18 November 2013 Faldaprevir plus pegylated interferon/ribavirin leads to early sustained response in people with HIV and HCV co-infection Liz Highleyman / 14 November 2013 The hepatitis C protease inhibitor faldaprevir plus pegylated interferon and ribavirin improved 4-week sustained response rates for HIV-positive people with genotype 1 hepatitis C co-infection in the STARTVerso4 trial, according to a ... Sofosbuvir + ribavirin produces sustained response in 76% of genotype 1 HIV/HCV co-infected people Liz Highleyman / 08 November 2013 An interferon-free regimen of sofosbuvir plus ribavirin taken for 24 weeks cured hepatitis C infection in three quarters of previously untreated HIV-positive people co-infected with hepatitis C virus (HCV) genotype 1, while ... High response rates with telaprevir triple therapy for HIV-positive men with acute hepatitis C Liz Highleyman / 05 November 2013 Adding telaprevir (Incivo or Incivek) to pegylated interferon and ribavirin shortens the duration of treatment and improves sustained response rates for HIV-positive men with acute hepatitis C virus (HCV) infection, according to ... Guidelines for the Management of Hepatitis Viruses in Adults Infected with HIV 2013 British HIV Association / 15 October 2013 Treating HCV genotypes 2 and 3 in HIV/HCV co-infected people Liz Highleyman / 10 October 2013 People co-infected with HIV and HCV, mostly with hepatitis C virus (HCV) genotype 3, responded about as well as HIV-negative people to interferon-based therapy after taking into account other factors associated ... People with HIV/HCV co-infection and advanced liver fibrosis can rapidly develop decompensated liver disease Michael Carter / 10 September 2013 People living with HIV who have hepatitis C virus (HCV) co-infection and advanced liver fibrosis can rapidly develop decompensated liver disease even though they do not have cirrhosis of the liver, ... Frequent coffee, chocolate consumption reduced liver enzymes in HIV/HCV coinfected patients Healio Hepatology / 02 September 2013 Smoking cannabis does not accelerate progression of liver disease in people with HIV/HCV co-infection Michael Carter / 06 August 2013 Smoking cannabis does not worsen liver disease in people with HIV and hepatitis C virus (HCV) co-infection, Canadian research published in the online edition of Clinical Infectious Diseases shows. “We found no evidence that ... HCV RNA Levels Stable in People on ART But Not on Anti-HCV Therapy International AIDS Society / 31 July 2013 ← Prev1...56789...10Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Transmission and prevention Diagnosis and monitoring Disease course and symptoms HCV and coinfections Living with HCV Treatment issues Side effects Therapies Liver transplants Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds